Antibodies, Monoclonal, Murine-Derived
This graph shows the total number of publications written about "Antibodies, Monoclonal, Murine-Derived" by people in the URMC Research Network by year, and whether "Antibodies, Monoclonal, Murine-Derived" was a major or minor topic of these publication.
Below are the most recent publications written about "Antibodies, Monoclonal, Murine-Derived" by people in Profiles.
-
Kellar RS, Lancaster JJ, Thai HM, Juneman E, Johnson NM, Byrne HG, Stansifer M, Arsanjani R, Baer M, Bebbington C, Flashner M, Yarranton G, Goldman S. Antibody to granulocyte macrophage colony-stimulating factor reduces the number of activated tissue macrophages and improves left ventricular function after myocardial infarction in a rat coronary artery ligation model. J Cardiovasc Pharmacol. 2011 May; 57(5):568-74.
-
Anolik J. Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care? J Rheumatol. 2011 Apr; 38(4):587-9.
-
Friedberg JW, Vose JM, Kelly JL, Young F, Bernstein SH, Peterson D, Rich L, Blumel S, Proia NK, Liesveld J, Fisher RI, Armitage JO, Grant S, Leonard JP. The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma. Blood. 2011 Mar 10; 117(10):2807-12.
-
Friedberg JW. Rituximab maintenance in follicular lymphoma: PRIMA. Lancet. 2011 Jan 1; 377(9759):4-6.
-
Advani RH, Chen H, Habermann TM, Morrison VA, Weller EA, Fisher RI, Peterson BA, Gascoyne RD, Horning SJ. Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI). Br J Haematol. 2010 Oct; 151(2):143-51.
-
Dougherty DW, Friedberg JW. Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy? Curr Hematol Malig Rep. 2010 Jul; 5(3):148-56.
-
Kahl BS, Cheson BD, Friedberg JW. Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapy. Clin Adv Hematol Oncol. 2010 May; 8(5):1-16.
-
Li J, Kuzin I, Moshkani S, Proulx ST, Xing L, Skrombolas D, Dunn R, Sanz I, Schwarz EM, Bottaro A. Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy. J Immunol. 2010 Jun 1; 184(11):6142-50.
-
Winter JN, Li S, Aurora V, Variakojis D, Nelson B, Krajewska M, Zhang L, Habermann TM, Fisher RI, Macon WR, Chhanabhai M, Felgar RE, Hsi ED, Medeiros LJ, Weick JK, Weller EA, Melnick A, Reed JC, Horning SJ, Gascoyne RD. Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494. Clin Cancer Res. 2010 Apr 15; 16(8):2435-42.
-
Sousou T, Friedberg J. Rituximab in indolent lymphomas. Semin Hematol. 2010 Apr; 47(2):133-42.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
